4th Quarter - Report
ALERE INC. for ALERE INC.
Firm
Client
Income
—
Expenses
$300,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA regulation of in-vitro diagnostic testing Importance of diagnostic testing to combat growth in antibiotic resistance Rapid point-of-care testing for influenza Emergency appropriations for development of rapid point-of-care Ebola diagnostics
| Lobbyist | Covered position, as disclosed |
|---|---|
| SETH M RADUS | — |
Medicare/Medicaid MMM
Rapid diagnostic testing to combat antibiotic resistant bacteria Implementation of the laboratory payment provision of the Protecting Access to Medicare Act of 2014, P.L. 113-93
| Lobbyist | Covered position, as disclosed |
|---|---|
| SETH M RADUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.